LeBlanc to present at NCCN 11th Annual Congress on Hematological Malignancies

Wednesday, September 21, 2016

Tom LeBlanc, MD, MA, assistant professor of medicine (Hematological Malignancies and Cellular Therapy) and member of Duke Cancer Institute, has been invited to present at the National Comprehensive Cancer Network's 11th Annual Congress: Hematological Malignancies on Oct. 1.

Dr. LeBlanc will present "Shared Decision Making at Key Points in the Management of Hematological Malignancies."

The conference addresses the increasingly complex treatment of hematological malignancies, with issues relating to pathology, transplantation, and new therapies. The congress will focus on the new approaches that have been incorporated into patient management, including the use of drugs, biologics and diagnostics.